Yongding Wu

Guangdong Key Laboratory Of Clinical Molecular Medicine And Diagnostics
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Regulatory B cells and SIVA1-LAG3 immune suppression predict poor prognosis in prostate cancer.

Regulatory B cells and SIVA1-LAG3 immune suppression predict poor prognosis in prostate cancer.

Journal: Biomolecules & biomedicine

Published: February 25, 2026

Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer.

Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer.

Journal: Acta biochimica et biophysica Sinica

Published: January 13, 2026

Exploring DNA topoisomerase II alpha in adrenocortical carcinoma through multi-omics analysis: a potential biomarker and therapeutic target.

Exploring DNA topoisomerase II alpha in adrenocortical carcinoma through multi-omics analysis: a potential biomarker and therapeutic target.

Journal: Acta biochimica et biophysica Sinica

Published: August 28, 2025

Omics integration identified CRIP2 as a key mediator of olaparib resistance in prostate cancer.

Omics integration identified CRIP2 as a key mediator of olaparib resistance in prostate cancer.

Journal: Translational andrology and urology

Published: August 01, 2025

S12micro: a machine learning-derived serum miRNA panel for high-performance pan-cancer diagnosis via liquid biopsy.

S12micro: a machine learning-derived serum miRNA panel for high-performance pan-cancer diagnosis via liquid biopsy.

Journal: International journal of surgery (London, England)

Published: June 19, 2025

ACACA depletion activates the cPLA2-arachidonic acid-NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer.

ACACA depletion activates the cPLA2-arachidonic acid-NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer.

Journal: Cell communication and signaling : CCS

Published: April 24, 2025

Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation.

Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation.

Journal: Cancer letters

Published: February 26, 2025

Characterization of the Biochemical Recurrence Prediction Ability and Progression Correlation of Peroxiredoxins Family in Prostate Cancer Based on Integrating Single-Cell RNA-Seq and Bulk RNA-Seq Cohorts.

Characterization of the Biochemical Recurrence Prediction Ability and Progression Correlation of Peroxiredoxins Family in Prostate Cancer Based on Integrating Single-Cell RNA-Seq and Bulk RNA-Seq Cohorts.

Journal: Cancer medicine

Published: October 11, 2024

Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway.

Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway.

Journal: MedComm

Published: March 15, 2024

Evaluation of glucocorticoid-related genes reveals GPD1 as a therapeutic target and regulator of sphingosine 1-phosphate metabolism in CRPC.

Evaluation of glucocorticoid-related genes reveals GPD1 as a therapeutic target and regulator of sphingosine 1-phosphate metabolism in CRPC.

Journal: Cancer letters

Published: September 21, 2023

FCGR3A: A new biomarker with potential prognostic value for prostate cancer.

FCGR3A: A new biomarker with potential prognostic value for prostate cancer.

Journal: Frontiers in oncology

Published: August 09, 2022

Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer.

Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer.

Journal: Frontiers in cell and developmental biology

Published: December 08, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026